Source: Annual Congress 2011 - Rare diffuse lung diseases
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Inoue, T. Arai, J. Otsuka, C. Sugimoto, M. Hirose, A. Natsumuro, Y. Iwaki, M. Nakagawa, S. Hayashi, M. Okada (Osaka, Japan). Lymphocytes populations in bloods and lungs in patients with auto-immune pulmonary alveolar proteinosis. Eur Respir J 2011; 38: Suppl. 55, 631

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary alveolar proteinosis Source: Respipedia Article Year: 2017 Our cases with pulmonary alveolar proteinosis Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs) Year: 2018 Reduced GM-CSF autoantibody in improved lung of autoimmune pulmonary alveolar proteinosis Source: Eur Respir J 2012; 39: 777-780 Year: 2012 The benefits of whole lung lavage in pulmonary alveolar proteinosis Source: Eur Respir J 2004; 23: 503-505 Year: 2004 Determinants of protein concentration in whole lung lavage of patients with pulmonary alveolar proteinosis Source: Annual Congress 2009 - From genetics to clinics in diffuse parenchymal lung diseases Year: 2009 Intercurrent intractable factors in autoimmune pulmonary alveolar proteinosis Source: Annual Congress 2009 - Various backgrounds in diffuse parenchymal lung disease Year: 2009 CD8+ T-cell alveolitis in familial pulmonary alveolar microlithiasis Source: Eur Respir J 2007; 30: 165-171 Year: 2007 Lung cysts in pulmonary alveolar proteinosis. Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs) Year: 2018 PAS-negative pulmonary alveolar proteinosis Source: Annual Congress 2008 - Rare clinical cases Year: 2008 Whole lung lavage (WLL) for patients with pulmonary alveolar proteinosis Source: Eur Respir J 2004; 24: Suppl. 48, 670s Year: 2004 KL-6 in whole lung lavage fluid of patients with pulmonary alveolar proteinosis Source: Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease Year: 2009 Surveillance of whole lung lavage for autoimmune pulmonary alveolar proteinosis in Japan Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 Mini-whole lung lavage to treat pulmonary alveolar proteinosis (PAP) Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key Year: 2020 Pulmonary alveolar proteinosis and idiopathic pulmonary hemosiderosis Source: International Congress 2019 – CCC Airway diseases Year: 2019 Long-term durable benefit after whole lung lavage in pulmonary alveolar proteinosis Source: Eur Respir J 2004; 23: 526-531 Year: 2004 Neutralizing capacity of autoantibody against GM-CSF in patients with autoimmune pulmonary alveolar proteinosis Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs) Year: 2018 Haemodynamically proven pulmonary hypertension in a patient with GATA2 deficiency-associated pulmonary alveolar proteinosis and fibrosis Source: Eur Respir J, 49 (5) 1700407; 10.1183/13993003.00407-2017 Year: 2017 Haemodynamically proven pulmonary hypertension in a patient with GATA2 deficiency-associated pulmonary alveolar proteinosis and fibrosis Source: Eur Respir J, 49 (5) 1700178; 10.1183/13993003.00178-2017 Year: 2017 Airway dendritic cell phenotypes in inflammatory diseases of the human lung Source: Eur Respir J 2007; 30: 878-886 Year: 2007 Idiopathic pulmonary alveolar proteinosis: GM CSF therapy and whole lung lavage a case report Source: Eur Respir J 2003; 22: Suppl. 45, 44s Year: 2003